Show simple item record

dc.contributor.authorFrank, AO
dc.contributor.authorVangamudi, B
dc.contributor.authorFeldkamp, MD
dc.contributor.authorSouza-Fagundes, EM
dc.contributor.authorLuzwick, JW
dc.contributor.authorCortez, D
dc.contributor.authorOlejniczak, ET
dc.contributor.authorWaterson, AG
dc.contributor.authorRossanese, OW
dc.contributor.authorChazin, WJ
dc.contributor.authorFesik, SW
dc.date.accessioned2020-08-14T15:39:24Z
dc.date.issued2014-03-27
dc.identifier.citationJournal of medicinal chemistry, 2014, 57 (6), pp. 2455 - 2461
dc.identifier.issn0022-2623
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3968
dc.identifier.eissn1520-4804
dc.identifier.doi10.1021/jm401730y
dc.description.abstractStapled helix peptides can serve as useful tools for inhibiting protein-protein interactions but can be difficult to optimize for affinity. Here we describe the discovery and optimization of a stapled helix peptide that binds to the N-terminal domain of the 70 kDa subunit of replication protein A (RPA70N). In addition to applying traditional optimization strategies, we employed a novel approach for efficiently designing peptides containing unnatural amino acids. We discovered hot spots in the target protein using a fragment-based screen, identified the amino acid that binds to the hot spot, and selected an unnatural amino acid to incorporate, based on the structure-activity relationships of small molecules that bind to this site. The resulting stapled helix peptide potently and selectively binds to RPA70N, does not disrupt ssDNA binding, and penetrates cells. This peptide may serve as a probe to explore the therapeutic potential of RPA70N inhibition in cancer.
dc.formatPrint-Electronic
dc.format.extent2455 - 2461
dc.languageeng
dc.language.isoeng
dc.publisherAMER CHEMICAL SOC
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCell Line
dc.subjectAlanine
dc.subjectPeptides
dc.subjectDNA, Single-Stranded
dc.subjectMicroscopy, Fluorescence
dc.subjectCrystallization
dc.subjectCrystallography, X-Ray
dc.subjectElectrophoretic Mobility Shift Assay
dc.subjectFluorescence Polarization
dc.subjectMagnetic Resonance Spectroscopy
dc.subjectAmino Acid Sequence
dc.subjectProtein Conformation
dc.subjectStructure-Activity Relationship
dc.subjectPenetrance
dc.subjectModels, Molecular
dc.subjectMolecular Sequence Data
dc.subjectTumor Suppressor Protein p53
dc.subjectReplication Protein A
dc.subjectDrug Discovery
dc.titleDiscovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A.
dc.typeJournal Article
rioxxterms.versionofrecord10.1021/jm401730y
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2014-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJournal of medicinal chemistry
pubs.issue6
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Target Evaluation and Molecular Therapeutics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Target Evaluation and Molecular Therapeutics
pubs.publication-statusPublished
pubs.volume57
pubs.embargo.termsNot known
icr.researchteamTarget Evaluation and Molecular Therapeutics
dc.contributor.icrauthorRossanese, Olivia


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0